Revolutionizing Distribution Intelligence: NielsenIQ (NIQ) Launches Advanced Global Distribution Intelligence on Market Data Platform gfknewron®
NIQ´s advanced distribution intelligence is now available on gfknewron®Integrated platform featuring distribution, retail and reseller market information alongside consumer insights and forecasting capabilities.
NielsenIQ (NIQ), a leading market intelligence company, today announced the global launch of gfknewron® Supply Chain on its state-of-the-art gfknewron® platform. For the first time, an intuitive, always-on AI-enabled platform will offer global distributor sales data, helping Tech & Durables clients manage their distribution and channel business. This tool helps manufacturers, distributors, suppliers, and the channel navigate the complexities of managing an end-to-end global supply chain and quickly adapt to market changes, delivering comprehensive distribution market insights in just a few clicks.
“Our clients and partners are now enabled to steer their supply value chain and distribution channel business with precision. By integrating global distribution intelligence with our platform's existing Point-of-Sale market intelligence, consumer insights, and forecasting capabilities, we are taking a major step forward in enabling our clients and partners to achieve greater success,” Tatjana Wismeth, Head of Distribution and Supply Chain Intelligence at NIQ commented. Tatjana added, “As a first, NIQ has managed to bring these complex data sets into one single platform, taking distribution and supply chain intelligence to the next level.”
gfknewron® Supply Chain offers Tech & Durables manufacturers and other users in-depth insights for sell-through market information based on distributor sales data from around 300 distributors across over 45 global markets. The data is updated weekly for 200 product groups across IT, Consumer Electronics, Office, Telecom and Small Domestic Appliances. With 24 individual sales channels being reported, users will receive an unparalleled view of distribution markets.
To enable this comprehensive market view, NIQ has collaborated with the Global Technology Distribution Council (GTDC) and its members. “The GTDC is a proud partner of NIQ and our members are excited to contribute to this great achievement as it truly simplifies working with distribution intelligence. The tool empowers users to easily analyze distributor sales information with great flexibility across markets. Our distributors and vendors are already looking forward to onboarding their teams and increasing their efficiency of sell-through market data analytics,” said Peter van den Berg, General Manager GTDC EMEA.
The tool facilitates quick access and seamless switching between different modules, allowing users to promptly understand growth drivers in distribution markets, brand and sales channel dynamics, price developments as well as identify top selling items on single SKU-level. This helps manufacturers and distributors steer their channel and sales management as well as to optimize their pricing in distribution markets. Thanks to NIQ´s geographical coverage, manufacturers and distributors benefit from global unified distribution intelligence across markets. The tool strengthens collaboration as analytics can easily be combined and shared across teams.
Together with Point-of-Sales information and Consumer Insights, profound market decisions can be made. NIQ´s Forecasting module on Point-of-Sale information complements the users’ view, providing insights on future market expectations.
This first of its kind tool is launching today, on April 7. To receive a live demonstration of the tool, further information, and contact details, click here: https://nielseniq.com/global/en/products/gfknewron-supply-chain-for-manufacturers.
About gfknewron®
gfknewron is an always-on platform that combines market, consumer and brand data supercharged with AI-powered recommendations. It enables companies to gain actionable and connected insights and act at speed to ignite sustainable growth. The platform offers three specific modules: “gfknewron Market” for market and competitor insights, “gfknewron Consumer” for an in-depth consumer understanding and “gfknewron Predict” that delivers recommendations for companies based on market data and AI-powered intelligence.
About NIQ
NielsenIQ (NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together two industry leaders with unparalleled global reach. Our global reach spans over 90 countries covering approximately 85% of the world’s population and more than $ 7.2 trillion in global consumer spend. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™.
For more information, please visit www.niq.com.
© 2025 Nielsen Consumer LLC. All Rights Reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250407569574/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom